
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CROMSOURCE has announced consolidation of its Hybrid Services Model and refined it to be able to provide its pharmaceutical, medical device, and biotechnology clients with an efficient alternative to traditional fully outsourced or functional service provider models.
To learn more, click






